Physical principles of renal replacement therapy applied to end stage renal disease patients

被引:6
|
作者
Canaud, B. [1 ]
机构
[1] CHU Montpellier, Hop Lapeyronie, Serv Nephrol Dialyse & Soins Intensifs, F-34295 Montpellier, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2009年 / 5卷 / 03期
关键词
Hemodialysis; Renal replacement therapy; End stage renal failure; HIGHLY PERMEABLE MEMBRANES; HIGH-FLUX DIALYZERS; CLINICAL-IMPLICATIONS; ACCESS RECIRCULATION; UREA CONCENTRATION; MASS-TRANSFER; HEMODIALYSIS; HEMODIAFILTRATION; KINETICS; DIALYSIS;
D O I
10.1016/j.nephro.2009.02.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
"Hemodialysis" is the generic term that refers to all forms of renal replacement therapy (RRT) able to restore periodically the "internal milieu" composition in end stage renal disease patients (ESRD). RRT includes several modalities (hemodialysis, hemofittration, hemodiafiltration) that induce basic physical principles (diffusion, convection, adsorption) via an exchange module (dialyser) and an electrolytic exchange solution (dialysis fluid). The cleansing property of the RRT depends on different factors: the treatment modality itself, the uremic toxin considered, patient's characteristic and the operational conditions (duration of treatment, session frequency, blood and dialysate flow rates). Solute instantaneous clearances reflect the dialyser's performances used in optimal conditions but not necessarily the body clearance. The effective solute body clearance is more difficult to assess in clinical practice since it includes some variables such as the treatment duration, the biological complexity of internal milieu and the variability of the patient/dialysis system interaction. The "dialysis adequacy" concept that governs the treatment efficacy in ESRD patients could not be reduced to the urea Kt/V ratio. It must integrate a selection of pertinent clinical and biological markers covering the complete spectrum of uremic abnormalities. Adequate knowledge of those basic physical principles that control the solute exchange in hemodialysis patient is highly recommended to any nephrologist who looks forward to improve treatment efficacy and reduce mortality in ESRD patients. (c) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:218 / 238
页数:21
相关论文
共 50 条
  • [1] Renal replacement therapy in patients with diabetes and end-stage renal disease
    Locatelli, F
    Pozzoni, P
    Del Vecchio, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : S25 - S29
  • [2] Active Tuberculosis in Patients Receiving Renal Replacement Therapy for End Stage Renal Disease
    Shah, K.
    Johnson, E.
    Rahman, A.
    McCaffferty, K.
    Kunst, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Survival probabilities of end stage renal disease patients on renal replacement therapy in Iran
    Rouchi, Alireza Heidary
    Mansournia, Mohammad Ali
    Aghighi, Mohammad
    Mahdavi-Mazdeh, Mitra
    NEPHROLOGY, 2018, 23 (04) : 331 - 337
  • [4] Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy
    Isberner, Nora
    Van Daele, Ruth
    Klinker, Hartwig
    Kraus, Sabrina
    Aghai, Fatemeh
    De Vlieger, Greet
    Kuypers, Dirk
    Debaveye, Yves
    Spriet, Isabel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (12) : 3322 - 3325
  • [5] Renal Replacement Therapy in Geriatric End-Stage Renal Disease Patients: A Clinical Approach
    Kooman, Jeroen P.
    Cornelis, Tom
    van der Sande, Frank M.
    Leunissen, Karel M. L.
    BLOOD PURIFICATION, 2012, 33 (1-3) : 171 - 176
  • [6] EFFECT OF RENAL REPLACEMENT THERAPY ON VISCOSITY IN END-STAGE RENAL-DISEASE PATIENTS
    FERIANI, M
    KIMMEL, PL
    KURANTSINMILLS, J
    BOSCH, JP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (02) : 131 - 139
  • [7] The Impact Of Renal Replacement Therapy On Sleep Disordered Breathing In Patients With End Stage Renal Disease
    Kaur, A.
    Link, B.
    Shemin, D.
    Risica, P.
    Martin, S.
    Parker, J.
    Millman, R.
    Dworkin, L.
    Bourjeily, G. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] The results of hepatitis B vaccination in patients with end stage renal disease on renal replacement therapy
    Kanatbayeva, A.
    Dikanbayeva, S.
    Chingayeva, G.
    Naushabayeva, A.
    Shepetov, A.
    Kabulbayev, K.
    Nigmatullina, N.
    Mustapayeva, N.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1572 - 1572
  • [9] Global variation in renal replacement therapy for end-stage renal disease
    Caskey, Fergus J.
    Kramer, Anneke
    Elliott, Robert F.
    Stel, Vianda S.
    Covic, Adrian
    Cusumano, Ana
    Geue, Claudia
    MacLeod, Alison M.
    Zwinderman, Aeilko H.
    Stengel, Benedicte
    Jager, Kitty J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (08) : 2604 - 2610
  • [10] Renal replacement therapy in Latin American end-stage renal disease
    Rosa-Diez, Guillermo
    Gonzalez-Bedat, Maria
    Pecoits-Filho, Roberto
    Marinovich, Sergio
    Fernandez, Sdenka
    Lugon, Jocemir
    Poblete-Badal, Hugo
    Elgueta-Miranda, Susana
    Gomez, Rafael
    Cerdas-Calderon, Manuel
    Almaguer-Lopez, Miguel
    Freire, Nelly
    Leiva-Merino, Ricardo
    Rodriguez, Gaspar
    Luna-Guerra, Jorge
    Bochicchio, Tomasso
    Garcia-Garcia, Guillermo
    Cano, Nuria
    Iron, Norman
    Cuero, Cesar
    Cuevas, Dario
    Tapia, Carlos
    Cangiano, Jose
    Rodriguez, Sandra
    Gonzalez, Haydee
    Duro-Garcia, Valter
    CLINICAL KIDNEY JOURNAL, 2014, 7 (04): : 431 - 436